Abstract | PURPOSE: METHODS AND MATERIAL: The subjects were 150 patients who underwent C-ion RT. Of these, 25 patients with low-risk prostate cancer received C-ion RT alone, whereas the remaining 125 patients with a high-risk tumor also received androgen deprivation therapy. Quality of life was assessed using the self-administered Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire in all patients three times. In addition, the University of California-Los Angeles Prostate Cancer Index (UCLA-PCI) was conducted in the low-risk patients. RESULTS: The FACT-General (FACT-G) and FACT-P scores at 12 months after treatment averaged over all 150 patients showed no significant change compared with those before C-ion RT. In FACT-P subscales, emotional well-being increased significantly just after and 12 months after treatment. In contrast, physical well-being (PWB) and social/family well-being (S/FWB) decreased significantly at 12 months, whereas the prostate cancer subscale (PCS) decreased significantly just after treatment. Average scores for FACT-G, FACT-P, PWB, S/FWB, and PCS for the 125 patients receiving hormone therapy showed substantial detrimental changes at 12 months. In contrast, those of the 25 low-risk patients who had no hormone therapy showed no significant change. Similarly no significant change in the average of the UCLA-PCI scores in the low-risk patients was seen at 12 months. CONCLUSIONS: Average QOL parameters reported by patients with localized prostate cancer treated with C-ion RT, in the absence of hormone therapy, showed no significant decrease 12 months after C-ion RT.
|
Authors | Masaru Wakatsuki, Hiroshi Tsuji, Hitoshi Ishikawa, Takeshi Yanagi, Tadashi Kamada, Takashi Nakano, Hiroyoshi Suzuki, Koichiro Akakura, Jun Shimazaki, Hirohiko Tsujii |
Journal | International journal of radiation oncology, biology, physics
(Int J Radiat Oncol Biol Phys)
Vol. 72
Issue 4
Pg. 1010-5
(Nov 15 2008)
ISSN: 1879-355X [Electronic] United States |
PMID | 18495370
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
|
Topics |
- Carbon Isotopes
(therapeutic use)
- Heavy Ion Radiotherapy
- Humans
- Japan
(epidemiology)
- Male
- Prostatic Neoplasms
(epidemiology, radiotherapy)
- Quality of Life
- Recovery of Function
- Surveys and Questionnaires
- Treatment Outcome
|